Works matching DE "LAPATINIB"

Results: 283
    1
    2
    3
    4
    5

    Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).

    Published in:
    Journal of Neuro-Oncology, 2017, v. 134, n. 2, p. 443, doi. 10.1007/s11060-017-2548-z
    By:
    • Christodoulou, Christos;
    • Kalogera-Fountzila, Anna;
    • Karavasilis, Vasilios;
    • Kouvatseas, George;
    • Papandreou, Christos;
    • Samantas, Epaminontas;
    • Varaki, Kalliopi;
    • Papadopoulos, Georgios;
    • Bobos, Mattheos;
    • Rallis, Grigorios;
    • Razis, Evangelia;
    • Goudopoulou, Athina;
    • Kalogeras, Konstantine;
    • Syrigos, Konstantinos;
    • Fountzilas, George
    Publication type:
    Article
    6

    An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).

    Published in:
    Journal of Neuro-Oncology, 2015, v. 123, n. 1, p. 85, doi. 10.1007/s11060-015-1764-7
    By:
    • DeWire, Mariko;
    • Fouladi, Maryam;
    • Turner, David;
    • Wetmore, Cynthia;
    • Hawkins, Cynthia;
    • Jacobs, Carmen;
    • Yuan, Ying;
    • Liu, Diane;
    • Goldman, Stewart;
    • Fisher, Paul;
    • Rytting, Michael;
    • Bouffet, Eric;
    • Khakoo, Yasmin;
    • Hwang, Eugene;
    • Foreman, Nicholas;
    • Stewart, Clinton;
    • Gilbert, Mark;
    • Gilbertson, Richard;
    • Gajjar, Amar
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

    Published in:
    2016
    By:
    • Sonnenblick, Amir;
    • de Azambuja, Evandro;
    • Agbor-tarh, Dominique;
    • Bradbury, Ian;
    • Campbell, Christine;
    • Yingjie Huang;
    • Dueck, Amylou C.;
    • Pritchard, Kathleen I.;
    • Wolff, Antonio C.;
    • Jackisch, Christian;
    • Lang, Istvan;
    • Untch, Michael;
    • Smith, Ian;
    • Boyle, Frances;
    • Binghe Xu;
    • Gomez, Henry;
    • Perez, Edith A.;
    • Piccart, Martine;
    • Azim Jr., Hatem A.;
    • Huang, Yingjie
    Publication type:
    journal article
    17
    18
    19
    20
    21
    22
    23

    A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.

    Published in:
    2017
    By:
    • Chia, Stephen K.;
    • Ellard, Susan L.;
    • Mates, Mihaela;
    • Welch, Stephen;
    • Mihalcioiu, Catalin;
    • Miller Jr, Wilson H.;
    • Gelmon, Karen;
    • Lohrisch, Caroline;
    • Kumar, Vikaash;
    • Taylor, Sara;
    • Hagerman, Linda;
    • Goodwin, Rachel;
    • Tao Wang;
    • Shingo Sakashita;
    • Tsao, Ming S.;
    • Eisenhauer, Elizabeth;
    • Bradbury, Penelope;
    • Miller, Wilson H Jr;
    • Wang, Tao;
    • Sakashita, Shingo
    Publication type:
    journal article
    24
    25
    26
    27
    28

    EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive Prolactinomas.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2021, v. 106, n. 2, p. e917, doi. 10.1210/clinem/dgaa805
    By:
    • Cooper, Odelia;
    • Bonert, Vivien S.;
    • Rudnick, Jeremy;
    • Pressman, Barry D.;
    • Lo, Janet;
    • Salvatori, Roberto;
    • Yuen, Kevin C. J.;
    • Fleseriu, Maria;
    • Melmed, Shlomo
    Publication type:
    Article
    29
    30
    31

    Brèves de l'AERIO.

    Published in:
    Oncologie (Tech Science Press), 2014, v. 16, n. 1, p. 69, doi. 10.1007/s10269-014-2367-6
    By:
    • Cochereau, D.;
    • Espie, M.;
    • Hadoux, J.;
    • Loriot, Y.
    Publication type:
    Article
    32

    Brèves de l'AERIO.

    Published in:
    Oncologie (Tech Science Press), 2012, v. 14, n. 12, p. 687, doi. 10.1007/s10269-012-2236-8
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Novel Cytochrome P450-3A4 Enzymatic Nanobiosensor for Lapatinib (a Breast Cancer Drug) Developed on a Poly(anilino-co-4-aminobenzoic Acid-Green-Synthesised Indium Nanoparticle) Platform.

    Published in:
    Biosensors (2079-6374), 2023, v. 13, n. 9, p. 897, doi. 10.3390/bios13090897
    By:
    • January, Jaymi Leigh;
    • Tshobeni, Ziyanda Zamaswazi;
    • Ngema, Nokwanda Precious Pearl;
    • Jijana, Abongile Nwabisa;
    • Iwuoha, Emmanuel Iheanyichukwu;
    • Mulaudzi, Takalani;
    • Douman, Samantha Fiona;
    • Ajayi, Rachel Fanelwa
    Publication type:
    Article
    46

    BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.

    Published in:
    Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1527, doi. 10.4143/crt.2018.598
    By:
    • Sung-Bae Kim;
    • In-Gu Do;
    • Janice Tsang;
    • Tae-You Kim;
    • Yoon-Sim Yap;
    • Cornelio, Gerardo;
    • Gyungyub Gong;
    • Soonmyung Paik;
    • Suee Lee;
    • Ting-Ying Ng;
    • Sarah Park;
    • Ho-Suk Oh;
    • Joanne Chiu;
    • Joohyuk Sohn;
    • Moonhee Lee;
    • Young-Jin Choi;
    • Eun Mi Lee;
    • Kyong-Hwa Park;
    • Nathaniel, Christos;
    • Jungsil Ro
    Publication type:
    Article
    47
    48
    49
    50